Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00348959
What this trial is testing

An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation

Who this might be right for
Hematological Malignancies
St. James's Hospital, Ireland 198
Very early researchNot Yet RecruitingNCT06837389
What this trial is testing

Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors

Who this might be right for
Relapsed or Refractory Hematological Malignancies
The First Affiliated Hospital with Nanjing Medical University 18
Early research (Phase 1)Study completedNCT05673460
What this trial is testing

A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Who this might be right for
Mature B-cell Neoplasms
Merck Sharp & Dohme LLC 7
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Testing effectiveness (Phase 2)Ended earlyNCT00281879
What this trial is testing

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 200
Not applicableEnded earlyNCT03743480
What this trial is testing

Early Palliative Care and Hematological Cancer Patients

Who this might be right for
Hematologic Neoplasms
Azienda USL Reggio Emilia - IRCCS 15
Not applicableStudy completedNCT02194868
What this trial is testing

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Assistance Publique - Hôpitaux de Paris 57
Not applicableLooking for participantsNCT03854318
What this trial is testing

Longitudinal Studies of Patient With FPDMM

Who this might be right for
Inherited Hematological DiseasesRare DiseasesFPDMM
National Human Genome Research Institute (NHGRI) 1,000
Not applicableNot Yet RecruitingNCT07621289
What this trial is testing

Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe

Who this might be right for
CancerAnticancer TreatmentCardiovascular Disease Risk Factor+2 more
University Hospital, Caen 10,000
Early research (Phase 1)Looking for participantsNCT07239323
What this trial is testing

In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

Who this might be right for
B-Acute Lymphoblastic LeukemiaB Cell Non-Hodgkin's LymphomaMultiple Myeloma
Chongqing Precision Biotech Co., Ltd 24
Early research (Phase 1)Active Not RecruitingNCT04684108
What this trial is testing

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Who this might be right for
Relapsed or Refractory Multiple MyelomaHematological Malignancy
Hangzhou Sumgen Biotech Co., Ltd. 61
Not applicableUnknownNCT04287309
What this trial is testing

CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS

Who this might be right for
Hematological Malignancy
Zhejiang University 20
Not applicableStudy completedNCT05763563
What this trial is testing

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Who this might be right for
LymphomaLeukemiaMyeloma
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableStudy completedNCT00881036
What this trial is testing

Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients

Who this might be right for
Hepatitis B
Kyoto University 33
Not applicableLooking for participantsNCT06373471
What this trial is testing

Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Who this might be right for
Hematologic MalignancyTreatment AdherenceTreatment Complication+2 more
Odense University Hospital 152
Early research (Phase 1)Study completedNCT00438178
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Gemin X 44
Testing effectiveness (Phase 2)UnknownNCT00524784
What this trial is testing

Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD

Who this might be right for
Graft Versus Host DiseaseHematological Malignancies
Hadassah Medical Organization 12
Not applicableUnknownNCT05963295
What this trial is testing

Toxoplasma Gondii Infection in Both Children and Adult Patients With Hematological Malignancies

Who this might be right for
Toxoplasmosis
Sohag University 50
Not applicableWithdrawnNCT04275154
What this trial is testing

Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy

Who this might be right for
Hematologic Neoplasms
University of Nebraska
Not applicableUnknownNCT05536154
What this trial is testing

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Who this might be right for
LymphomaMultiple Myeloma
The Affiliated People's Hospital of Ningbo University 68
Next Page